These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31186048)

  • 1. DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs.
    Hoff K; Lemme M; Kahlert AK; Runde K; Audain E; Schuster D; Scheewe J; Attmann T; Pickardt T; Caliebe A; Siebert R; Kramer HH; Milting H; Hansen A; Ammerpohl O; Hitz MP
    Clin Epigenetics; 2019 Jun; 11(1):89. PubMed ID: 31186048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Ventricular and Atrial Cardiomyocyte Subtypes from Human-Induced Pluripotent Stem Cells.
    Nakanishi-Koakutsu M; Takaki T; Miki K; Yoshida Y
    Methods Mol Biol; 2021; 2320():135-149. PubMed ID: 34302655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
    Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
    J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
    Lickiss B; Hunker J; Bhagwan J; Linder P; Thomas U; Lotay H; Broadbent S; Dragicevic E; Stoelzle-Feix S; Turner J; Gossmann M
    J Pharmacol Toxicol Methods; 2024; 128():107529. PubMed ID: 38857637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes.
    Goldfracht I; Protze S; Shiti A; Setter N; Gruber A; Shaheen N; Nartiss Y; Keller G; Gepstein L
    Nat Commun; 2020 Jan; 11(1):75. PubMed ID: 31911598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
    Paci M; Hyttinen J; Aalto-Setälä K; Severi S
    Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae.
    Mannhardt I; Eder A; Dumotier B; Prondzynski M; Krämer E; Traebert M; Söhren KD; Flenner F; Stathopoulou K; Lemoine MD; Carrier L; Christ T; Eschenhagen T; Hansen A
    Toxicol Sci; 2017 Jul; 158(1):164-175. PubMed ID: 28453742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes.
    Chirikian O; Goodyer WR; Dzilic E; Serpooshan V; Buikema JW; McKeithan W; Wu H; Li G; Lee S; Merk M; Galdos F; Beck A; Ribeiro AJS; Paige S; Mercola M; Wu JC; Pruitt BL; Wu SM
    Sci Rep; 2021 Feb; 11(1):3026. PubMed ID: 33542270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid modulation guides human-induced pluripotent stem cell differentiation towards left or right ventricle-like cardiomyocytes.
    Zhang H; Sen P; Hamers J; Sittig T; Woestenburg B; Moretti A; Dendorfer A; Merkus D
    Stem Cell Res Ther; 2024 Jun; 15(1):184. PubMed ID: 38902843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of basal and norepinephrine-induced cAMP and I
    Iqbal Z; Ismaili D; Dolce B; Petersen J; Reichenspurner H; Hansen A; Kirchhof P; Eschenhagen T; Nikolaev VO; Molina CE; Christ T
    Cell Signal; 2021 Jun; 82():109970. PubMed ID: 33677066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.
    Bizy A; Guerrero-Serna G; Hu B; Ponce-Balbuena D; Willis BC; Zarzoso M; Ramirez RJ; Sener MF; Mundada LV; Klos M; Devaney EJ; Vikstrom KL; Herron TJ; Jalife J
    Stem Cell Res; 2013 Nov; 11(3):1335-47. PubMed ID: 24095945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
    Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model.
    Cumberland MJ; Euchner J; Azad AJ; T N Vo N; Kirchhof P; Holmes AP; Denning C; Gehmlich K
    F1000Res; 2023; 12():1224. PubMed ID: 38298530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Transcriptional Profiling of Chamber-Specific Human Cardiac Myocytes Derived from Pluripotent Stem Cells.
    Lucena-Cacace A; Yoshida Y
    Methods Mol Biol; 2021; 2320():219-232. PubMed ID: 34302661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
    Andrysiak K; Stępniewski J; Dulak J
    Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.